These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 11128602

  • 1. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Stefferl A, Brehm U, Linington C.
    J Neural Transm Suppl; 2000; (58):123-33. PubMed ID: 11128602
    [Abstract] [Full Text] [Related]

  • 2. Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire.
    Mathey E, Breithaupt C, Schubart AS, Linington C.
    Eur J Immunol; 2004 Aug; 34(8):2065-71. PubMed ID: 15259003
    [Abstract] [Full Text] [Related]

  • 3. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C.
    Glia; 2001 Nov; 36(2):220-34. PubMed ID: 11596130
    [Abstract] [Full Text] [Related]

  • 4. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
    Marta CB, Oliver AR, Sweet RA, Pfeiffer SE, Ruddle NH.
    Proc Natl Acad Sci U S A; 2005 Sep 27; 102(39):13992-7. PubMed ID: 16172404
    [Abstract] [Full Text] [Related]

  • 5. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH, Linker RA.
    Expert Opin Ther Targets; 2012 May 27; 16(5):451-62. PubMed ID: 22494461
    [Abstract] [Full Text] [Related]

  • 6. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG).
    Brehm U, Piddlesden SJ, Gardinier MV, Linington C.
    J Neuroimmunol; 1999 Jun 01; 97(1-2):9-15. PubMed ID: 10408984
    [Abstract] [Full Text] [Related]

  • 7. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.
    von Büdingen HC, Tanuma N, Villoslada P, Ouallet JC, Hauser SL, Genain CP.
    J Clin Immunol; 2001 May 01; 21(3):155-70. PubMed ID: 11403222
    [Abstract] [Full Text] [Related]

  • 8. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice.
    Morris-Downes MM, Smith PA, Rundle JL, Piddlesden SJ, Baker D, Pham-Dinh D, Heijmans N, Amor S.
    J Neuroimmunol; 2002 Apr 01; 125(1-2):114-24. PubMed ID: 11960647
    [Abstract] [Full Text] [Related]

  • 9. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.
    Zhou D, Srivastava R, Nessler S, Grummel V, Sommer N, Brück W, Hartung HP, Stadelmann C, Hemmer B.
    Proc Natl Acad Sci U S A; 2006 Dec 12; 103(50):19057-62. PubMed ID: 17142321
    [Abstract] [Full Text] [Related]

  • 10. Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions.
    Merkler D, Schmelting B, Czéh B, Fuchs E, Stadelmann C, Brück W.
    Mult Scler; 2006 Aug 12; 12(4):369-74. PubMed ID: 16900750
    [Abstract] [Full Text] [Related]

  • 11. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls.
    Haase CG, Guggenmos J, Brehm U, Andersson M, Olsson T, Reindl M, Schneidewind JM, Zettl UK, Heidenreich F, Berger T, Wekerle H, Hohlfeld R, Linington C.
    J Neuroimmunol; 2001 Mar 01; 114(1-2):220-5. PubMed ID: 11240035
    [Abstract] [Full Text] [Related]

  • 12. Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.
    Matsumoto Y, Park IK, Hiraki K, Ohtani S, Kohyama K.
    Immunology; 2009 Sep 01; 128(1 Suppl):e250-61. PubMed ID: 19175799
    [Abstract] [Full Text] [Related]

  • 13. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.
    Bernard CC, Johns TG, Slavin A, Ichikawa M, Ewing C, Liu J, Bettadapura J.
    J Mol Med (Berl); 1997 Feb 01; 75(2):77-88. PubMed ID: 9083925
    [Abstract] [Full Text] [Related]

  • 14. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.
    Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu JM, Gardinier MV, Dornmair K, Linington C.
    J Neuroimmunol; 1995 Dec 01; 63(1):17-27. PubMed ID: 8557821
    [Abstract] [Full Text] [Related]

  • 15. Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis.
    Bourquin C, Iglesias A, Berger T, Wekerle H, Linington C.
    Eur J Immunol; 2000 Dec 01; 30(12):3663-71. PubMed ID: 11169409
    [Abstract] [Full Text] [Related]

  • 16. Genetic variation in myelin oligodendrocyte glycoprotein expression and susceptibility to experimental autoimmune encephalomyelitis.
    Pagany M, Jagodic M, Bourquin C, Olsson T, Linington C.
    J Neuroimmunol; 2003 Jun 01; 139(1-2):1-8. PubMed ID: 12799014
    [Abstract] [Full Text] [Related]

  • 17. Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
    Pacini G, Ieronymaki M, Nuti F, Sabatino G, Larregola M, Aharoni R, Papini AM, Rovero P.
    J Pept Sci; 2016 Jan 01; 22(1):52-8. PubMed ID: 26663200
    [Abstract] [Full Text] [Related]

  • 18. Rhesus monkeys are highly susceptible to experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein: characterisation of immunodominant T- and B-cell epitopes.
    Kerlero de Rosbo N, Brok HP, Bauer J, Kaye JF, 't Hart BA, Ben-Nun A.
    J Neuroimmunol; 2000 Oct 02; 110(1-2):83-96. PubMed ID: 11024537
    [Abstract] [Full Text] [Related]

  • 19. Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents.
    Breithaupt C, Schäfer B, Pellkofer H, Huber R, Linington C, Jacob U.
    J Immunol; 2008 Jul 15; 181(2):1255-63. PubMed ID: 18606679
    [Abstract] [Full Text] [Related]

  • 20. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F, Poewe W, Berger T.
    Brain; 1999 Nov 15; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.